Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Systemic Sclerosis: the Role of Autoantibodies and Their Blockade in the Disease Pathogenesis. In Vitro and in Vivo Experimental Models

NCT06502678 is registered in ClinicalTrials.gov with IRCCS Ospedale San Raffaele as lead sponsor.

NCT NCT06502678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06502678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Systemic Sclerosis: the Role of Autoantibodies and Their Blockade in the Disease Pathogenesis. In Vitro and in Vivo Experimental Models
Lead sponsor
IRCCS Ospedale San Raffaele
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2024
Completion date
December 31, 2025
Enrollment
6 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

understand pathogenicity of ssc-specific antibodies in ssc and the effect of antibody blockade in vitro